BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Actor Scott Foley and TESARO Team Up to Empower Ovarian Cancer Care Partners Through New Phase of Not on My Watch Movement

  In a New Public Service Announcement, Foley Reveals for the First Time his Personal Story of Caring for his Mother Following Ovarian Cancer Recurrence

  February 26, 2019

   · 

  6 min read
• 

  Business

  Lynparza Passes Phase III Pancreatic Cancer Trial With Flying Colors

  The drug is being developed and commercialized jointly by AstraZeneca and Merck. It has already been approved for multiple indications in advanced ovarian cancer and metastatic breast cancer.

  February 26, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Bio NC

  IQVIA Report: Global Drug Spending to Hit $1.5 Trillion by 2023

  The IQVIA Institute for Human Data Science published its Study on Global Medicine Spending. One of the findings is that total drug spending is expected to climb to more than $1.5 trillion by 2023. That’s a 50 percent increase from 2014.

  February 26, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Gang of 7 Pharma Execs Grilled by Congress

  U.S. Senator Chuck Grassley (R-Iowa) set the tone early, mentioning his constituents rationing drugs because of high prices or “leaving their prescription on the pharmacy counter because it costs too much,” but acknowledging that innovations “take time and money.”

  February 26, 2019

   · 

  4 min read

   · 

  Mark Terry
• FDA

  Medtronic Resolute(TM) Drug-Eluting Stent (DES) Platform Receives Expanded Indication for Treatment of Chronic Total Occlusion (CTO)

  FDA Approval Allows Interventional Cardiologists Access to Resolute DES Technology to Treat De Novo CTO

  February 26, 2019

   · 

  3 min read
• Business

  Promore Pharma AB (publ) Year-end report 2018

  The past year, 2018, was in many ways a decisive year for Promore Pharma

  February 26, 2019

   · 

  6 min read
• Drug Development

  Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers

  Medigene AG announced that it has dosed the first patient in its first-in-human clinical trial with its TCR therapy candidate MDG1011.

  February 26, 2019

   · 

  6 min read
• Job Trends

  Why a Common Antibiotic Treating Diarrhea is Failing

  In the world of superbugs Clostridioides difficile, a bacterium that causes diarrhea and colitis, is among the most stubborn.

  February 26, 2019

   · 

  2 min read
• Pharm Country

  Four Private Equity Women Investor Network (PEWIN) Members Raise a Total of $1.5 Billion for their Respective Funds

  Members Adele Oliva (1315 Capital), Hollie Haynes (Luminate Capital Partners), Kristina Heinze (ParkerGale) and Kate Mitchell (Scale Venture Partners) have each successfully closed a new fund.

  February 26, 2019

   · 

  4 min read
• BioMidwest

  Ardagh leads local beverage can recycling effort

  Ardagh Group, a leading beverage can manufacturer, is making the connection between environmental friendliness and charity.

  February 26, 2019

   · 

  3 min read